The home healthcare market is predicted to capture a valuation of US$ 3.2 billion in 2023 and is estimated to grow at US$ 4.4 billion by 2033. The market is estimated to register a CAGR of 3.1% during the forecast period. Factors that drive the market size are given below:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Prominent manufacturers are developing advanced healthcare devices to enhance the quality of treatment among patients. These manufacturers are making highly supportive devices that are easy to access, increasing patients' demand for home healthcare. Manufacturers' focus on providing environment-friendly medical devices propels market opportunities during the forecast period.
The adoption of telemedicine and digital monitoring equipment in emergencies are surging market opportunities. This equipment reduces a load of treatment due to its feature of easy to access and monitor patient's health. These are the few factors advancing the market growth with the manufacturer's innovations in the healthcare sector.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 3.1% |
| Market Valuation (2023) | US$ 3.2 billion |
| Market Valuation (2033) | US$ 4.4 billion |
Principal Consultant
According to Future Market Insights, the global home healthcare market is predicted at a healthy 3.1% CAGR during the forecast period. Historically, the market registered a CAGR of 2.6% between 2017 and 2022.
Introducing easy-to-use and portable medical devices have shifted patients' demand from hospitals to home healthcare in recent years. Increase in daily medical checkups and elder age people staying at home are fuelling the demand for home healthcare. The adoption of Artificial Intelligence and the Internet of Things are developing smart devices which have taken the place of traditional healthcare systems.
Through these smart devices patients can check and manage their insulin levels with the use of insulin pens. The adoption of remote system devices for monitoring and reducing the overall cost are increasing the demand for home healthcare. Improvement in the quality of healthcare through relationship-based home care models for the disabled and geriatrics is fueling the market expansion.
The market is estimated to reach US$ 4.4 billion during the forecast period. Historically, the market stood at US$ 3.1 billion from 2017 to 2022.
| Segments | Product Type |
|---|---|
| Top Category | Infusion Systems |
| Historic CAGR | 2.6% |
| Forecast CAGR | 3.0% |
| Segments | Application |
|---|---|
| Top Category | Stoma Care |
| Historic CAGR | 2.6% |
| Forecast CAGR | 3.6% |
Based on product type, the infusion systems dominate the global market by occupying a CAGR of 3.0% during the forecast period. The adoption of infusion systems in-home healthcare services boosts market opportunities. As a result, infusion systems capture a huge revenue in the global market to supply liquid to patients’ bodies.
The rising adoption of infusion pumps is to deliver nutrients, pain relievers, antibiotics, and other medical doses. Clinical settings such as hospitals, nursing homes, and private residences drive market growth.
Additional features such as sirens, security measures, and other warnings are growing the sales of infusion systems. Historically, the infusion systems captured a CAGR of 2.6% between 2017 and 2022.
The stoma care application is expected to account for a CAGR of 3.6% during the forecast period. Adopting stoma care in home healthcare contributes to treat infections and rashes. The nurses and stoma specialists provide stoma care at home, traveling and ensuring convenience to the patients.
Intravenous (IV) medication is also expected to offer potential growth avenues to manufacturers of home healthcare systems. By 2033, the application area would represent a multi-billion-dollar opportunity. Historically, stoma care secured a CAGR of 2.6% between 2017 and 2022.
Top Countries Data Table Mentioned Below:
| Country | United States |
|---|---|
| CAGR (2017 to 2022) | 2.9% |
| CAGR (2023 to 2023) | 3.5% |
| Valuation (2023 to 2033) | US$ 1.3 billion |
| Country | United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.2% |
| CAGR (2023 to 2023) | 3.9% |
| Valuation (2023 to 2033) | US$ 357.5 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 2.4% |
| CAGR (2023 to 2023) | 2.9% |
| Valuation (2023 to 2033) | US$ 316 million |
| Country | Japan |
|---|---|
| CAGR (2017 to 2022) | 2.9% |
| CAGR (2023 to 2023) | 3.4% |
| Valuation (2023 to 2033) | US$ 246.6 million |
| Country | South Korea |
|---|---|
| CAGR (2017 to 2022) | 1.9% |
| CAGR (2023 to 2023) | 2.4% |
| Valuation (2023 to 2033) | US$ 49.7 million |
The United States secures a CAGR of 3.5% with a valuation of US$ 1.3 billion during the forecast period. Rising advanced healthcare infrastructure, the shift towards in-home healthcare services, and the growing generic population are expanding the United States home healthcare market. The increasing demand for nursing homes for private home health aides in the United States propels market share.
The growing aging population, wearable patient monitoring devices, and disposable income are accelerating the demand for home healthcare in the United States. Historically, the United States captured a CAGR of 2.9% between 2017 and 2022.
Innovation in Medical Home Healthcare Drives China Market?
China is expected to progress at significant growth by securing a CAGR of 2.9% with a valuation of US$ 316 million during the forecast period. The growing significant urbanization, healthcare infrastructure, and advanced healthcare equipment drive China's home healthcare market. The rising chronic patients is increasing the adoption of home healthcare products and services.
Increasing medical supervision, individualized healthcare services, and home medical devices are the important factors driving the China market. Historically, China captured a CAGR of 2.4% between 2017 and 2022.
Japan is securing a significant CAGR of 3.4% with a valuation of US$ 246.6 million during the forecast period. Furthermore, Japan is continuously growing the Asia Pacific market share through the initiative hospital at-home program, which reduced the cost of treatment by over 30%. In addition, the government is promoting home healthcare services to uplift the Japan home healthcare market growth.
There are various healthcare sectors that offer home care to patients, including baby and mother care, elderly care, and others. Additionally, the adoption of home healthcare also includes personalized and medical supervision healthcare services. Historically, Japan captured a CAGR of 2.9% between 2017 and 2022.
The United Kingdom secures a CAGR of 3.9% with valuation of US$ 357.5 million during the forecast period. The rising disposable income, patients' preferences for treatment at home, and chronic diseases are increasing the demand for home healthcare in the country. In addition, rising government initiatives presence of healthcare providers and key manufacturers are the crucial factors bolstering the United Kingdom home healthcare market. Historically, the United Kingdom captured a CAGR of 3.2% between 2017 and 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The prominent players are fragments of the global market by occupying a significant revenue. The market players are developing innovative devices and medical equipment to maintain daily check-ups at home. These devices are advanced and equipped with artificial intelligence, and new technology is flourishing the market expansion.
Healthcare providers prefer these devices to check patients' daily healthcare routine at the hospital, home, or any place. These players focus on developing easy-to-use equipment and adopting several marketing strategies to increase home healthcare sales. The rising popularity of online distribution channel is easy to reach relevant consumers and acquire huge market revenue.
Key Players operating in the Market are:
Recent Developments
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa, Türkiye |
| Key Segments Covered | Product Type, Application, Region |
| Key Companies Profiled | Coloplast A/S; B. Braun Melsungen AG; Baxter International Inc.; Hollister Incorporated; Becton Dickinson and Co; ConvaTec Group Plc; Medtronic plc.; Amedisys Home Health and Hospice Care; American Well; CVS Health; Humana Inc.; LHC Group Inc.; Kindred Healthcare |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The home healthcare market is predicted to record a 3.1% CAGR through 2033.
Hospital sector drives the home healthcare market.
The home healthcare market is expected to surpass US$ 4.4 billion by 2033.
The home healthcare market is anticipated to be US$ 3.2 billion in 2023.
The United States leads the home healthcare market during the forecast period.
1. Executive Summary | Home Healthcare Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Infusion Systems 5.3.1.1. Ambulatory Infusion Pumps 5.3.1.2. Implantable Infusion Pumps 5.3.1.3. Infusion Disposable Sets 5.3.1.4. Syringe Pumps 5.3.1.5. Volumetric Pumps 5.3.2. Pressure Relief Devices 5.3.2.1. Mattress Overlays 5.3.2.2. Mattresses 5.3.2.3. Specialty Beds 5.3.3. Hydrocolloids Dressings 5.3.4. Hydrofibres Dressings 5.3.5. Hydrogels Dressings 5.3.6. Semi-Permeable Films Dressings 5.3.7. Superabsorbents Dressings 5.3.8. Wound Contact Layers 5.3.9. Gauze Sponges 5.3.10. Gauzes 5.3.11. Sponges 5.3.12. Ostomy Drainage Bags 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Total Parenteral Nutrition 6.3.2. IV Medication 6.3.3. Pressure Ulcer 6.3.4. Stoma Care 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia 7.3.6. Oceania 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Argentina 9.2.1.4. Rest of Latin America 9.2.2. By Product Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. United Kingdom (UK) 10.2.1.2. Germany 10.2.1.3. France 10.2.1.4. Italy 10.2.1.5. Spain 10.2.1.6. Russia 10.2.1.7. Rest of Europe 10.2.2. By Product Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Product Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Indonesia 12.2.1.3. Thailand 12.2.1.4. Malaysia 12.2.1.5. Rest of South Asia 12.2.2. By Product Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.4. Key Takeaways 13. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Product Type 13.2.3. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. South Africa 14.2.1.2. Türkiye 14.2.1.3. GCC Countries 14.2.1.4. Rest of Middle East and Africa 14.2.2. By Product Type 14.2.3. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product Type 15.1.2.2. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product Type 15.2.2.2. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product Type 15.3.2.2. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product Type 15.4.2.2. By Application 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product Type 15.5.2.2. By Application 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product Type 15.6.2.2. By Application 15.7. Germany 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product Type 15.7.2.2. By Application 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product Type 15.8.2.2. By Application 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product Type 15.9.2.2. By Application 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product Type 15.10.2.2. By Application 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product Type 15.11.2.2. By Application 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product Type 15.12.2.2. By Application 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product Type 15.13.2.2. By Application 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product Type 15.14.2.2. By Application 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product Type 15.15.2.2. By Application 15.16. Indonesia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product Type 15.16.2.2. By Application 15.17. Thailand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product Type 15.17.2.2. By Application 15.18. Malaysia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product Type 15.18.2.2. By Application 15.19. Australia 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product Type 15.19.2.2. By Application 15.20. New Zealand 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product Type 15.20.2.2. By Application 15.21. South Africa 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product Type 15.21.2.2. By Application 15.22. Türkiye 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product Type 15.22.2.2. By Application 15.23. GCC Countries 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product Type 15.23.2.2. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Coloplast A/S 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. B. Braun Melsungen AG 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Baxter International Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Hollister Incorporated 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Becton Dickinson and Co 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. ConvaTec Group Plc 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Medtronic plc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Amedisys Home Health and Hospice Care 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. American Well 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. CVS Health 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Humana Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. LHC Group Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Kindred Healthcare 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Home Healthcare Market
